Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Crohn's disease Stories

2011-12-03 11:29:54

In a paper published in the December 2011 issue of Experimental Biology and Medicine, a team of scientists at the University of Illinois, Urbana-Champaign led by Rex Gaskins, PhD have demonstrated that both microbial and host inflammatory factors modulate sulfomucin production in a human cell line, LS174T, that models intestinal goblet cells. Sulfomucins, one of two primary types of acidomucins secreted by intestinal goblet cells, provide crucial protection to the intestinal mucosa....

2011-12-02 07:00:00

HORSHAM, Pa., Dec. 2, 2011 /PRNewswire/ -- The winners of IBD Icons, a national campaign to celebrate the achievements of those living beyond inflammatory bowel disease (IBD), have been decided by America after a month-long, national vote. On December 4, Season 10 American Idol finalist Casey Abrams will recognize the winners onstage at a concert to kick off the Zappos.com Rock 'n' Roll Las Vegas Marathon and 1/2 Marathon. The event will benefit the Crohn's & Colitis Foundation of...

2011-12-01 01:34:57

New research published in the Journal of Leukocyte Biology suggests that oral ingestion of apple polyphenols can suppress T cell activation and ameliorate experimental colitis in mice Here's another reason why "an apple a day keeps the doctor away"–according to new research findings published in the Journal of Leukocyte Biology (https://www.jleukbio.org), oral ingestion of apple polyphenols (antioxidants found in apple peels) can suppress T cell activation to prevent colitis in mice....

2011-11-30 09:25:00

<font size="2" face="Arial"> Week of December 1-7 first Crohn's and Colitis Awareness Week </font> NEW YORK, Nov. 30, 2011 /PRNewswire-USNewswire/ -- The week of December 1-7 has been designated by the Crohn's & Colitis Foundation of America (CCFA) as Crohn's and Colitis Awareness Week in order to encourage all Americans to join in the effort to find cures for these diseases, help raise awareness and support research. Senate Resolution 199 expresses appreciation to...

2011-11-30 09:11:00

OAKLAND, Calif., Nov. 30, 2011 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its 2012 Innovator Awards Program for Inflammatory Bowel Disease (IBD). The program supports "out-of-the-box" innovative research projects that are potentially transformative to the Foundation's efforts to diagnose, treat and/or cure IBD. While the peak age of onset for IBD is 15 to 30 years old, it can occur at any age. Recently, IBD has become one of the most significant chronic diseases...

2011-11-30 09:00:00

ATLANTA, Nov. 30, 2011 /PRNewswire/ -- UCB, Inc., a leading biopharmaceutical company at the forefront of immunology treatments and research, announced the 30 recipients of the 2011 UCB Crohn's and Me Scholarship. This scholarship recognizes outstanding individuals from across the country who are pursuing higher education as part of their efforts to live beyond the limitations of Crohn's disease. "UCB is committed to making a difference in the lives of people affected by Crohn's disease,"...

2011-11-21 11:42:12

Certain patients with inflammatory bowel disease (IBD) may have an increased risk of skin cancer, which is intensified by the use of immunosuppressant medications, according to two new studies in Gastroenterology, the official journal of the American Gastroenterological Association. Immunosuppressants are commonly used in the treatment of IBD. In the first study, researchers found that both past and present exposure to thiopurines (a widely used class of immunosuppressants) significantly...

2011-10-31 09:00:00

ATLANTA, Oct. 31, 2011 /PRNewswire/ -- UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, will present new data on Cimzia® (certolizumab pegol) at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Washington D.C. from October 28 to November 2. "Cimzia data presented this year at ACG highlights the role that inflammatory biomarkers may play in increasing the understanding of the...

2011-10-31 08:00:00

Fecal Transplants, Hepatitis C, Efficacy of Probiotics, Smoking's Impact on GI Health, Vitamin D in IBD Therapy, Adult IBS and Childhood Trauma Link Among Featured Science WASHINGTON, Oct. 31, 2011 /PRNewswire-USNewswire/ -- Many of the world's preeminent gastroenterologists have convened this week for the American College of Gastroenterology's (ACG) 76th Annual Scientific Meeting at the Gaylord National Hotel and Conference Center at the National Harbor to review the latest scientific...

2011-10-28 09:00:00

ATLANTA, Oct. 28, 2011 /PRNewswire/ -- UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is marking the 2011 American College of Gastroenterology (ACG) meeting in Washington, D.C. by reinforcing its commitment to improving the lives of patients with Crohn's disease. At this year's ACG meeting, a large body of UCB data will highlight the potential role of inflammatory biomarkers in treatment of moderate to severe Crohn's disease. "ACG is an...